Division of Metabolism, Endocrinology, and Diabetes (A.F.T., Z.S., H.L.), University of Michigan, Ann Arbor.
Division of Nephrology, Endocrinology and Vascular Medicine, Tohoku University Graduate School of Medicine, Sendai, Miyagi, Japan (Y.T., F.S.).
Hypertension. 2024 Mar;81(3):604-613. doi: 10.1161/HYPERTENSIONAHA.123.21910. Epub 2024 Jan 4.
Primary aldosteronism (PA) has been broadly dichotomized into unilateral and bilateral forms. Adrenal vein sampling (AVS) lateralization indices (LI) ≥2 to 4 are the standard-of-care to recommend unilateral adrenalectomy for presumed unilateral PA. We aimed to assess the rates and characteristics of residual PA after AVS-guided adrenalectomy.
We conducted an international, retrospective, cohort study of patients with PA from 7 referral centers who underwent unilateral adrenalectomy based on LI≥4 on baseline and/or cosyntropin-stimulated AVS. Aldosterone synthase (CYP11B2) immunohistochemistry and next generation sequencing were performed on available formalin-fixed paraffin-embedded adrenal tissue.
The cohort included 283 patients who underwent AVS-guided adrenalectomy, followed for a median of 326 days postoperatively. Lack of PA cure was observed in 16% of consecutive patients, and in 22 patients with lateralized PA on both baseline and cosyntropin-stimulated AVS. Among patients with residual PA postoperatively, 73% had multiple CYP11B2 positive areas within the resected adrenal tissue (versus 23% in those cured), wherein mutations were most prevalent (63% versus 33% in those cured). In adjusted regression models, independent predictors of postoperative residual PA included Black versus White race (odds ratio, 5.10 [95% CI, 1.45-17.86]), AVS lateralization only at baseline (odds ratio, 8.93 [95% CI 3.00-26.32] versus both at baseline and after cosyntropin stimulation), and CT-AVS disagreement (odds ratio, 2.75 [95% CI, 1.20-6.31]).
Multifocal, asymmetrical bilateral PA is relatively common, and it cannot be excluded by robust AVS lateralization. Long-term postoperative monitoring should be routinely pursued, to identify residual PA and afford timely initiation of targeted medical therapy.
原发性醛固酮增多症(PA)可广泛分为单侧和双侧形式。肾上腺静脉采样(AVS)侧化指数(LI)≥2 至 4 是推荐单侧肾上腺切除术的标准,用于诊断单侧 PA。我们旨在评估 AVS 引导的肾上腺切除术治疗后残留 PA 的发生率和特征。
我们对来自 7 家转诊中心的 PA 患者进行了一项国际、回顾性、队列研究,这些患者基于基线和/或促皮质素刺激的 AVS 上的 LI≥4 进行了单侧肾上腺切除术。对可获得的福尔马林固定石蜡包埋肾上腺组织进行醛固酮合酶(CYP11B2)免疫组织化学和下一代测序。
该队列包括 283 名接受 AVS 引导的肾上腺切除术的患者,术后中位随访 326 天。连续患者中有 16%未治愈,在基线和促皮质素刺激的 AVS 双侧均为单侧 PA 的 22 名患者中也未治愈。术后残留 PA 的患者中,73%的患者在切除的肾上腺组织中存在多个 CYP11B2 阳性区域(而在治愈的患者中为 23%),其中 突变最为常见(在治愈的患者中为 63%,而在治愈的患者中为 33%)。在调整后的回归模型中,术后残留 PA 的独立预测因素包括黑种人而非白种人(比值比,5.10 [95%CI,1.45-17.86])、仅在基线时 AVS 侧化(比值比,8.93 [95%CI,3.00-26.32],而基线和促皮质素刺激后)和 CT-AVS 不一致(比值比,2.75 [95%CI,1.20-6.31])。
多灶性、不对称性双侧 PA 较为常见,不能通过可靠的 AVS 侧化排除。应常规进行长期术后监测,以发现残留的 PA,并及时开始有针对性的药物治疗。